Joint Training and Research Program on Lifespan Regulation Mechanisms in Health and Disease

Acronym

HealthAge

Description of the granted funding

Aging is an inexorable homeostatic failure of complex but largely unknown aetiology that leads to increased vulnerability to disease with enormous consequences on the quality of individual lives and the overall cost to society. Although, aging is driven by limitations in somatic maintenance, it is also subject to regulation by evolutionarily highly conserved molecular pathways. Indeed, macromolecular damage may drive the functional decline with aging; however, a battery of conserved, longevity assurance mechanisms may set the pace on how rapidly damage builds up and function is lost over time. Human efforts over the last centuries have succeeded in substantially lengthening lifespan, allowing aging to become a common feature of western societies. However, The discouraging complexity of the aging process, the noticeable lack of tools to study it, and a shortage of experimentally tractable model systems have made it significantly challenging to unravel the molecular basis of the processes that cause loss of bodily functions and degeneration of cells and tissues with advancing age. HealthAge was carefully designed to create a joint European program of excellence in training and research with a core intellectual focus on the functional role of “Lifespan Regulation Mechanisms in Health and Disease”. To tackle this, HealthAge combines top-level, state-of-the-art and interdisciplinary research skills that range from basic molecular mechanisms and ‘omics’ level understanding to translational research and clinical applications. This interdisciplinary strategy will allow us to gain functional insight into the fundamental mechanisms regulating longevity as well as to develop a series of rationalized intervention strategies aimed at counteracting age-related diseases.
Show more

Starting year

2019

End year

2023

Granted funding

GENEVIA TECHNOLOGIES OY
280 805.76 €
Participant
NAGI BIOSCIENCE SA (CH)
281 276.64 €
Participant
PANEPISTIMIO KRITIS (EL)
Participant
ETAIRIA DIACHIRISIS KAI ANAPTIXIS EPISTIMONIKOU KAI TECHNOLOGIKOU PARKOU KRITIS AE (EL)
Participant
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH)
281 276.64 €
Participant
PROTATOUANS - ETAIREIA EREYNAS VIOTECHNOLOGIAS MONOPROSOPI ETAIREIA PERIORISMENIS EYTHINIS (EL)
243 017.64 €
Participant
FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) (ES)
250 904.88 €
Participant
UNIVERSITE DE LAUSANNE (CH)
243 017.55 €
Participant
SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI DI TRIESTE (IT)
Participant
UNIVERSITAET ZU KOELN (DE)
Participant
KLINIKUM DER UNIVERSITAET ZU KOELN (DE)
252 788.4 €
Participant
TEL AVIV UNIVERSITY (IL)
263 500.92 €
Participant
UNIVERSITAT BASEL (CH)
281 276.64 €
Participant
ACADEMISCH ZIEKENHUIS GRONINGEN (NL)
265 619.88 €
Participant
UNIVERSITE DE GENEVE (CH)
Participant
UNIVERSITA DEGLI STUDI DI PADOVA (IT)
261 499.68 €
Participant
IDRYMA TECHNOLOGIAS KAI EREVNAS (EL)
486 035.28 €
Coordinator
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (FR)
274 802.04 €
Participant

Amount granted

3 940 624 €

Funder

European Union

Funding instrument

Marie Skłodowska-Curie Innovative Training Networks (ITN)

Framework programme

Horizon 2020 Framework Programme

Call

Programme part
EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions (5220)
Fostering new skills by means of excellent initial training of researchers (5221)
Topic
Innovative Training Networks (MSCA-ITN-2018)
Call ID
H2020-MSCA-ITN-2018

Other information

Funding decision number

812830

Identified topics

ageing, health